VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $25,413,000 | -71.5% | 250,000 | -50.0% | 3.32% | -64.7% |
| Q3 2015 | $89,190,000 | -38.2% | 500,000 | -23.1% | 9.42% | -28.0% |
| Q2 2015 | $144,398,000 | +11.8% | 650,000 | 0.0% | 13.08% | -0.9% |
| Q1 2015 | $129,103,000 | +11.2% | 650,000 | -19.9% | 13.20% | -4.0% |
| Q4 2014 | $116,126,000 | +9.1% | 811,443 | 0.0% | 13.76% | +32.3% |
| Q3 2014 | $106,461,000 | +10.9% | 811,443 | +6.6% | 10.39% | +16.0% |
| Q2 2014 | $96,008,000 | +279.2% | 761,242 | +253.0% | 8.96% | +143.6% |
| Q4 2013 | $25,317,000 | – | 215,644 | – | 3.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bruce & Co., Inc. | 850,000 | $6,987,000 | 2.38% |